Replimune Email Format

Biotechnology Research
201-500 employees
Woburn, MA, USA

Replimune is a biotechnology company pioneering the development of novel oncolytic immunotherapies designed to activate powerful anti-tumor responses and revolutionize cancer treatment.

Find contacts at Replimune

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@replimune.com

Company Overview

Industry
Biotechnology Research
Founded
2015
Headquarters
Woburn, MA, USA
Revenue
$100M+
FUNDING Stage
Public
Key Executives
Sushil Patel (Chief Executive Officer), Emily Hill (Chief Financial Officer)

Tech Stack

Veeva Vault

CMS

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Replimune?

Replimune uses the first.last format, so Jane Smith would be jane.smith@replimune.com.

What cancer indications does Replimune's lead program RP1 target in its clinical trials?

Replimune's RP1, also known as vusolimogene oderparepvec, is being studied in advanced melanoma, non-melanoma skin cancers such as Merkel cell carcinoma and basal cell carcinoma, and skin cancer in organ transplant recipients across multiple clinical trials.

Where does Replimune manufacture its oncolytic immunotherapy products?

Replimune operates its own 63,000 square foot manufacturing facility in the United States, giving the company direct control over the production of its HSV-1-based oncolytic immunotherapy pipeline candidates.

How does Replimune's RPx platform work to fight cancer?

Replimune's RPx platform uses an engineered HSV-1 backbone with a dual mechanism: it directly destroys tumor cells at the injection site and triggers a broader systemic anti-tumor immune response, targeting both injected and distant lesions.

Who leads Replimune and how can I find the right contact there for outreach?

Replimune is led by CEO Sushil Patel and CFO Emily Hill, and the company employs 453 people. If you are building a targeted outreach list for Replimune, Clay can help you identify and verify the right contacts using the first.last@replimune.com email format.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles